Table of Contents for the Digital Edition of Drug Information Journal - January 2010 Drug Information Journal - January 2010 Table of Contents Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place Biogeneric Regulatory Policies in China and India: A Comparison Study Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun Review of Pediatric Drug Development: Concepts and Applications Drug Information Journal - January 2010 Drug Information Journal - January 2010 - (Page intro) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page Cover1) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page Cover2) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page i) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page ii) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page iii) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page iv) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page v) Drug Information Journal - January 2010 - Drug Information Journal - January 2010 (Page vi) Drug Information Journal - January 2010 - Table of Contents (Page vii) Drug Information Journal - January 2010 - Table of Contents (Page viii) Drug Information Journal - January 2010 - Table of Contents (Page ix) Drug Information Journal - January 2010 - Table of Contents (Page x) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 1) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 2) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 3) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 4) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 5) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 6) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 7) Drug Information Journal - January 2010 - Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial (Page 8) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 9) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 10) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 11) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 12) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 13) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 14) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 15) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 16) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 17) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 18) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 19) Drug Information Journal - January 2010 - Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials (Page 20) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 21) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 22) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 23) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 24) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 25) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 26) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 27) Drug Information Journal - January 2010 - Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Double-blind Paradigm (Page 28) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 29) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 30) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 31) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 32) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 33) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 34) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 35) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 36) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 37) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 38) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 39) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 40) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 41) Drug Information Journal - January 2010 - Statistical Computing Environments and the Practice of Statistics in the Biopharmaceutical Industry (Page 42) Drug Information Journal - January 2010 - Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions (Page 43) Drug Information Journal - January 2010 - Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions (Page 44) Drug Information Journal - January 2010 - Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions (Page 45) Drug Information Journal - January 2010 - Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions (Page 46) Drug Information Journal - January 2010 - Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions (Page 47) Drug Information Journal - January 2010 - Leveraging Technology to Increase Efficiency and Quality for Regulatory Submissions (Page 48) Drug Information Journal - January 2010 - Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place (Page 49) Drug Information Journal - January 2010 - Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place (Page 50) Drug Information Journal - January 2010 - Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place (Page 51) Drug Information Journal - January 2010 - Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place (Page 52) Drug Information Journal - January 2010 - Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place (Page 53) Drug Information Journal - January 2010 - Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents They Must Put in Place (Page 54) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 55) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 56) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 57) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 58) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 59) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 60) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 61) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 62) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 63) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 64) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 65) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 66) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 67) Drug Information Journal - January 2010 - Biogeneric Regulatory Policies in China and India: A Comparison Study (Page 68) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 69) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 70) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 71) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 72) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 73) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 74) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 75) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 76) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 77) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 78) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 79) Drug Information Journal - January 2010 - Discussion Based on the Survey Results of Authorities’ Inquiries During NDA Review in Japan (Page 80) Drug Information Journal - January 2010 - Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team (Page 81) Drug Information Journal - January 2010 - Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team (Page 82) Drug Information Journal - January 2010 - Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team (Page 83) Drug Information Journal - January 2010 - Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team (Page 84) Drug Information Journal - January 2010 - Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team (Page 85) Drug Information Journal - January 2010 - Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team (Page 86) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 87) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 88) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 89) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 90) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 91) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 92) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 93) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 94) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 95) Drug Information Journal - January 2010 - Issues With Medical Device Spontaneous Reporting and Improvements Through MedSun (Page 96) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page 97) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page 98) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page 99) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page 100) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page 101) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page 102) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page Cover3) Drug Information Journal - January 2010 - Review of Pediatric Drug Development: Concepts and Applications (Page Cover4) http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0910 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0710 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0510 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0310 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0909 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0709 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0509 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0309 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0908 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0708 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0508 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0308 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1107 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0907 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0707 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0507 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0307 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.